Skip to main content

Table 3 Logistic regression analysis of predictors of mortality in 59 adults with HIV treated for pulmonary tuberculosis in Jos, Nigeria

From: Evaluation of gene xpert for routine diagnosis of HIV-associated tuberculosis in Nigeria: A prospective cohort study

 

Unadjusted Analysis

Adjusted Analysis

 

OR

95% CI

P-value

AOR

95% CI

P-value

Xpert positive

0.32

0.08–1.32

0.12

0.67

0.11–4.05

0.66

Age, years

1.03

0.97–1.10

0.19

1.04

0.96–1.12

0.31

BMI < 18.5 Kg/m2

1.90

0.41–8.82

0.41

-

-

-

Sex, Female

4.52

0.87–23.50

0.07

5.63

0.69–45.93

0.11

3 or more TB symptoms

0.66

0.11–3.81

0.65

-

-

-

Recent CD4 count <200 cells/mm3

0.87

0.21–3.50

0.84

-

-

-

Recent CD4 count (cell/mm3)

1.00

0.99–1.00

0.66

-

-

-

On ART

0.11

0.02–0.77

0.03

0.10

0.01–0.93

0.04

Time to treatment (days)

0.99

0.95–1.05

0.87

-

-

-

  1. OR Odds ratio, AOR Adjusted odds ratio, CI Confidence interval, BMI Body mass index, TB tuberculosis, ART Antiretroviral therapy
  2. Variables with p < 0.2 in the bivariate analysis were included in the adjusted model